After failed phase 3, Accera appoints neuroscience vet to help revive fortunes

Two months ago, Acerra registered a late-stage flop for its much-derided “brain food” candidate AC-1204 in Alzheimer’s, but now the company is …

Link to Full Article

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!